GlassScriptPhysician profile
Jose S Bendayan
NPI 1740352806
$3,027.31
in general payments reported to CMS, 2019-2025
17 companies · $48.60 in 2025
The $48.60 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,234 · 2020: $85.17 · 2021: $332 · 2022: $176 · 2023: $151 · 2025: $48.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $2,145.00 | 2019 | |
| Abbvie INC. | $191.24 | 2020-2023 | Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $164.72 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $82.56 | 2020-2021 | |
| Intuitive Surgical, INC. | $73.28 | 2021 | |
| Allergan, INC. | $58.03 | 2019-2021 | |
| Coopersurgical, INC. | $53.69 | 2021-2022 | |
| Exeltis, USA INC. | $47.83 | 2022-2025 | Slynd |
| Amag Pharmaceuticals, INC. | $43.22 | 2021 | |
| Mayne Pharma Commercial LLC | $30.42 | 2021 | |
| Pfizer INC. | $24.75 | 2023 | |
| Evofem Biosciences, INC. | $23.43 | 2022 | |
| Agile Therapeutics, INC. | $22.49 | 2022 | |
| Shield Therapeutics INC | $21.31 | 2023 | Accrufer |
| Avion Pharmaceuticals | $20.06 | 2023 | Balcoltra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.09 | 2019 | |
| Duchesnay USA Incorporated | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Bendayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.